BeStock  
Stocks › Biotechnology › SMMT

Summit Therapeutics SMMT

US equityMarket cap rank #716Biotechnology
$17.08 +$0.17 (+0.98%)
Market open · Oct 1, 11:50 am ET · After hours $16.92 +0.06%
Open$16.82
Prev close$16.91
Day range$16.59 – $17.18
Volume2.66M
Market cap$13.62B
P/E (TTM)–
Dividend yield–

Ownership & positioning

Who holds it, who is betting against it, and where the big money is moving

Institutional ownership21.3%-0.25 pts vs. prior quarter
Institutions holding287-2 vs. prior quarter

The five largest holders on file together own 85.9% of shares outstanding.

Largest holders

  • Robert Duggan71.94%
  • Mahkam Zanganeh4.53%
  • Baker Bros. Advisors LP4.11%
  • Akeso, Inc.4.02%
  • FMR1.26%
  • State Street Global Advisors1.20%
  • BlackRock1.19%
  • Vanguard Capital Management, LLC0.84%

By investor type

  • Individual/Insider76.88%
  • Mutual Fund8.64%
  • Hedge Fund7.22%
  • Public Company4.99%
  • Private Company0.18%
  • Sovereign Wealth Fund0.18%
  • Government Pension Fund0.04%
  • Insurance Company0.01%

No ownership data on file for this stock.

Discussion

No comments yet — be the first to weigh in on SMMT.

Leave a comment

Scroll to Top